FDAFDA · Food and drugs·Recall number D-0097-2023
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,
Published January 11, 2023 · Recall initiated: December 29, 2022
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility: Bags have the potential to leak.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HEPARIN SODIUM
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide in the USA.
- Lot
- Lot: 5935283, Exp. 12/01/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.